ID-PROSTATE
Financiado
Integrated Diagnostics for Prostate Cancer
Quantib Prostate is an AI-enhanced solution to enable an integrated diagnostic care pathway for prostate cancer between urologist, radiologist and pathologist. Prostate cancer is the most prevalent form of cancer in men and their...
Quantib Prostate is an AI-enhanced solution to enable an integrated diagnostic care pathway for prostate cancer between urologist, radiologist and pathologist. Prostate cancer is the most prevalent form of cancer in men and their second leading cause of death. Recent high-impact clinical trials have demonstrated the utility of prostate MRI in the care-pathway: 5x fewer missed cancers, 25% fewer biopsies. These trials resulted in changes in care standards per 2019, now recommending MRI prior to every biopsy, resulting in a strong demand increase for prostate MRI scans.
Conventional radiology reading capacity cannot keep pace with that demand due to long staff training times. Quantib Prostate addresses this issue with AI-algorithms that detect potential tumors and workflow enhancements that reduce reporting time.
This project allows Quantib to accelerate and further improve Quantib Prostate.
ver más
Duración del proyecto: 23 meses
Fecha Inicio: 2020-07-14
Fecha Fin: 2022-06-30
Fecha Fin: 2022-06-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2022-06-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
3M€
Líder del proyecto
QUANTIB BV
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
391.99K€ |
Participante